Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome.
about
Redox regulation by Nrf2: gatekeeping for the basal and diabetes-induced expression of thioredoxin interacting proteinThe ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradationThioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformationThioredoxin and ventricular remodelingThioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseasesThioredoxin-interacting protein regulates glucose metabolism and affects cytoplasmic streaming in mouse oocytesTxnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout miceCLIC5 mutant mice are resistant to diet-induced obesity and exhibit gastric hemorrhaging and increased susceptibility to torporTandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing moleculesAdenosine-containing molecules amplify glucose signaling and enhance txnip expression.Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate.Thioredoxin-interacting protein gene expression via MondoA is rapidly and transiently suppressed during inflammatory responsesDisruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity.Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome.Particle size of latex beads dictates IL-1β production mechanism.Diminished AMPK signaling response to fasting in thioredoxin-interacting protein knockout miceThe emerging role of the thioredoxin system in angiogenesisThioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injuryThioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway.Txnip balances metabolic and growth signaling via PTEN disulfide reductionThioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.Induction of the metabolic regulator Txnip in fasting-induced and natural torpor.Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein.Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence.Targeted metabolomics connects thioredoxin-interacting protein (TXNIP) to mitochondrial fuel selection and regulation of specific oxidoreductase enzymes in skeletal muscle.An expanded family of arrestins regulate metabolism.Overexpression of thioredoxin-binding protein 2 increases oxidation sensitivity and apoptosis in human lens epithelial cells.Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care.W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.
P2860
Q23923916-3A3FD29C-5066-4DF4-9791-F2D9F95E3AFBQ24294762-D3DD496E-BB7B-4FD8-8218-D0C0B8F88C74Q24622771-D8549862-F3C7-4012-A53F-4DDD0AE5E706Q24683258-6797A87A-919C-4EE8-85DA-45B4B8402850Q27003070-89D82A66-434D-4885-9F6B-3153167E9E19Q27310131-D6208EE6-8B8A-47B0-8745-56DEB164AF01Q27332439-14D9D82D-B7B9-4DA7-BC10-E2880B12A7E5Q28512655-6D4AC3F0-F8E1-45AA-868C-4A153C1720C7Q33520238-A45524AA-8BC3-4B33-9864-72335B53DB87Q33642473-7E4B8BC6-1C7B-4CAC-87F6-81A0214F7BB2Q33707944-8841ED94-C8A5-437D-9DE9-22EF9BABE8A0Q33869780-2C939672-BAED-4A6C-9F0A-3D3C547BA58CQ33977405-EB9FBD66-CC91-4AFB-B0D7-EEC628B5EE07Q34056017-AA527F67-2CCB-4335-BF1D-E578EBC09276Q34631988-D9ADAACD-6EF8-4F85-ABAF-ADC0CF685209Q34696555-00FA7230-04DC-4A46-A3CE-CB28B4558466Q34731377-D37E35B1-22DE-437F-B568-82112EDC7BACQ34848969-873EC765-EFA5-408D-AD7D-AD66B57DCD4FQ34934470-1821473B-60AF-41D6-982F-193EE7D1688EQ35123800-389492E4-C886-43E5-92A3-E9FA2FE0E10BQ35634417-03801FA9-9848-4374-8F9F-58EA2E414DF5Q35640549-DA898996-6325-4E03-A1D9-999CDCB6F2C4Q35906034-8E920FE8-99FF-4E4A-A912-1F1F5C84A09AQ36202895-8D893084-B06B-4D1C-8A6A-3E51DF326049Q36499261-73E6DB88-971F-455E-B7C4-05DE56AACB29Q36629722-44913EDC-D05F-4B53-B4A4-2E2950604CD7Q37087720-9C7C603F-CB65-41CE-A8B1-F6952FA41848Q37375712-B3594CEF-2B96-4430-ADC7-8448FCE8A999Q37413641-1110E95C-16AD-4CD6-A56E-0EC042D34D72Q37644877-8C4994BF-8B63-4EA3-9A67-BBC2DBCEBE8AQ37653225-EFF5ADE4-97D5-4702-AB66-F13463CE1AB6Q38004211-2E5D10BB-388A-41B1-AFE3-9A517E9A2272Q39216011-76F67BD1-5B5E-4233-A357-F15A65BB0B96Q41928061-6B34E801-E6BE-47A4-A51F-0E7CD7ED8401Q51002471-C51C194C-A821-434D-BA7B-D2B045CB4514Q52709221-9A65BAE0-378B-4629-A666-5B4B4B12BB9B
P2860
Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Impaired fatty acid utilizatio ...... animal model of Reye syndrome.
@en
Impaired fatty acid utilization in thioredoxin binding protein-2
@nl
type
label
Impaired fatty acid utilizatio ...... animal model of Reye syndrome.
@en
Impaired fatty acid utilization in thioredoxin binding protein-2
@nl
prefLabel
Impaired fatty acid utilizatio ...... animal model of Reye syndrome.
@en
Impaired fatty acid utilization in thioredoxin binding protein-2
@nl
P2093
P356
P1433
P1476
Impaired fatty acid utilizatio ...... animal model of Reye syndrome.
@en
P2093
Hajime Nakamura
Hiromi Hirata
Hiroshi Masutani
Junji Yodoi
Shin-ichi Oka
Shu-ichi Yamada
Toru Yoshida
Wenrui Liu
Yoichi Shinkai
P304
P356
10.1096/FJ.05-4439FJE
P407
P577
2005-10-27T00:00:00Z